Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study on the Use of Glucophage XR® Therapy in the Management of Patients With Type 2 Diabetes

NCT01336673 is registered in ClinicalTrials.gov with Merck KGaA, Darmstadt, Germany as lead sponsor.

NCT NCT01336673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01336673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study on the Use of Glucophage XR® Therapy in the Management of Patients With Type 2 Diabetes
Lead sponsor
Merck KGaA, Darmstadt, Germany
Phase
Observational
Overall status
Terminated
Start date
June 30, 2011
Completion date
June 30, 2013
Enrollment
518 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2, gi side effect